BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7680950)

  • 1. Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest Oncology Group study.
    Bukowski RM; Wolf M; Kulander BG; Montie J; Crawford ED; Blumenstein B
    Cancer; 1993 Apr; 71(8):2631-8. PubMed ID: 7680950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
    Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe MJ; Droz JP
    Am J Clin Oncol; 1997 Apr; 20(2):184-8. PubMed ID: 9124197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
    Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
    Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
    Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.
    Hainsworth JD; Williams SD; Einhorn LH; Birch R; Greco FA
    J Clin Oncol; 1985 May; 3(5):666-71. PubMed ID: 2582097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extragonadal germ cell tumors. Clinicopathologic findings and treatment experience in 12 patients.
    McLeod DG; Taylor HG; Skoog SJ; Knight RD; Dawson NA; Waxman JA
    Cancer; 1988 Mar; 61(6):1187-91. PubMed ID: 2449276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extragonadal abdominal germ cell cancers.
    Gonzalez-Vela JL; Villalona-Calero MA; Torkelson JL; Fraley EE; Kennedy BJ
    Am J Clin Oncol; 1992 Aug; 15(4):308-10. PubMed ID: 1381144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of extragonadal germ-cell tumors.
    Daugaard G; Rørth M; Hansen HH
    Eur J Cancer Clin Oncol; 1983 Jul; 19(7):895-9. PubMed ID: 6192996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
    Lopes LF; Macedo CR; Aguiar Sdos S; Barreto JH; Martins GE; Sonaglio V; Milone M; Lima ER; Almeida MT; Lopes PM; Watanabe FM; D'Andrea ML; Pianovski MA; Melaragno R; Vianna SM; Moreira ME; Bruniera P; de Oliveira CZ
    J Clin Oncol; 2016 Feb; 34(6):603-10. PubMed ID: 26729441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
    Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
    J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
    Hartmann JT; Einhorn L; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 2001 Mar; 19(6):1641-8. PubMed ID: 11250992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
    Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.
    Anthoney DA; McKean MJ; Roberts JT; Hutcheon AW; Graham J; Jones W; Paul J; Kaye SB
    Br J Cancer; 2004 Feb; 90(3):601-6. PubMed ID: 14760371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Result of treatment for advanced germ cell tumor in the last decade].
    Ishioka J; Kageyama Y; Inoue M; Fukui N; Numao N; Saito K; Ichiyanagi N; Tanak M; Hyochi N; Fukuda H; Higashi Y
    Nihon Hinyokika Gakkai Zasshi; 2010 Mar; 101(3):539-46. PubMed ID: 20387513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mediastinal germ cell tumors: an intergroup study.
    Billmire D; Vinocur C; Rescorla F; Colombani P; Cushing B; Hawkins E; London WB; Giller R; Lauer S
    J Pediatr Surg; 2001 Jan; 36(1):18-24. PubMed ID: 11150432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of refractory germ cell cancer with Etoposide.
    Lederman GS; Garnick MB; Canellos GP; Richie JP
    J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extragonadal germ cell tumor: a clinical study.
    Bassetto MA; Pasini F; Franceschi T; Mustacchi G; Cetto GL
    Anticancer Res; 1995; 15(6B):2751-4. PubMed ID: 8669858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.